Abstract
Constitutive androstane receptor (CAR, NR1I3), which is under consideration in this review, is a member of the superfamily of nuclear receptors. However, certain features distinguish CAR from the variety of nuclear receptors. First, this receptor has structural features that allow it to display constitutive activity in the absence of a ligand and to interact in a species-specific manner with a huge number of ligands diverse in chemical structure and origin. Second, recently many researchers are focused on CAR because the significance is increasingly shown of its influence on a variety of physiological functions, such as gluconeogenesis, metabolism of xenobiotics, fatty acids, bilirubin, and bile acids, hormonal regulation, etc. In addition to the fundamental scientific interest, the study of CAR is of practical importance because changes in CAR activity can lead to disorders in physiological processes, which finally can result in changes in pathological states. However, despite intensive studies, many mechanisms are still unclear, which makes it difficult to understand the role of CAR in the overall picture of molecular regulation of physiological processes. This review analyzes the features and diversity of the functions of CAR.
Similar content being viewed by others
Abbreviations
- CAR:
-
constitutive androstane receptor
- DBD:
-
DNA-binding domain
- LBD:
-
ligand-binding domain
- NR:
-
nuclear receptor
- PB:
-
phenobarbital
- RXR:
-
retinoic acid receptor
- SRC:
-
steroid receptor coactivator
- XRE:
-
xenobiotic-responsive element
References
Committee Nuclear Receptors Nomenclature (1999) Cell, 97, 161–163.
Sonoda, J., Pei, L., and Evans, R. (2008) FEBS Lett., 582, 2–9.
Wei, P., Zhang, J., Egan-Hafley, M., Liang, S., and Moore, D. (2000) Nature, 407, 920–923.
Ueda, A., Hamadeh, H. K., Webb, H. K., Yamamoto, Y., Sueyoshi, T., Afshari, C. A., Lehmann, J. M., and Negishi, M. (2002) Mol. Pharmacol., 61, 1–6.
Kassam, A., Winrow, C. J., Fernandez-Rachubinski, F., Capone, J. P., and Rachubinski, R. A. (2000) J. Biol. Chem., 275, 4345–4350.
Sugatani, J., Yamakawa, K., Yoshinari, K., Machida, T., Takagi, H., Mori, M., Kakizaki, S., Sueyoshi, T., Negishi, M., and Miwa, M. (2002) Biochem. Biophys. Res. Commun., 292, 492–497.
Eloranta, J. J., and Kullak-Ublick, G. A. (2005) Arch. Biochem. Biophys., 433, 397–412.
Baes, M., Gulick, T., Choi, H. S., Martinoli, M. G., Simha, D., and Moore, D. D. (1994) Mol. Cell. Biol., 14, 1544–1552.
Forman, B. M., Tzameli, I., Choi, H. S., Chen, J., Simha, D., Seol, W., Evans, R. M., and Moore, D. D. (1998) Nature, 395, 612–615.
Timsit, Y. E., and Negishi, M. (2007) Steroids, 72, 231–246.
Pustylnyak, V. O., Gulyaeva, L. F., and Lyakhovich, V. V. (2007) Biochemistry (Moscow), 72, 608–617.
Kanno, Y., Suzuki, M., Miyazaki, Y., Matsuzaki, M., Nakahama, T., Kurose, K., Sawada, J., and Inouye, Y. (2007) Biochim. Biophys. Acta, 1773, 934–944.
Smirnov, A. N. (2002) Biochemistry (Moscow), 67, 957–977.
Kishimoto, M., Fujiki, R., Takezawa, S., Sassaki, Y., Nakamura, T., Yamaoka, K., Kitagawa, H., and Kato, S. (2006) Endocrine J., 53, 157–172.
Li, H., and Wang, H. (2010) Expert. Opin. Drug. Metab. Toxicol., 6, 409–426.
Xu, R. X., Lambert, M. H., Wisely, B. B., Warren, E. N., Weinert, E. E., Waitt, G. M., Williams, J. D., Collins, J. L., Moore, L. B., Willson, T. M., and Moore, J. T. (2004) Mol. Cell, 16, 919–928.
Aranda, A., and Pascual, A. (2001) Physiol. Rev., 81, 1270–1304.
Wright, E., Busby, S. A., Wisecarver, S., Vincent, J., Griffin, P. R., and Fernandez, E. J. (2011) Structure, 19, 37–44.
Honkakoski, P., Zelko, I., Sueyoshi, T., and Negishi, M. (1998) Mol. Cell. Biol., 18, 5652–5658.
Wagner, M., Halilbasic, E., Marschall, H. U., Zollner, G., Fickert, P., Langner, C., Zatloukal, K., Denk, H., and Trauner, M. (2005) Hepatology, 42, 420–430.
Sueyoshi, T., Moore, R., Sugatani, J., Matsumura, Y., and Negishi, M. (2008) Mol. Pharmacol., 73, 1113–1121.
Auerbach, S. S., Ramsden, R., Stoner, M. A., Verlinde, C., Hassett, C., and Omiecinski, C. J. (2003) Nucleic Acids Res., 31, 3194–3207.
Zelko, I., and Negishi, M. (2000) Biochem. Biophys. Res. Commun., 277, 1–6.
Wang, H., Faucette, S., Sueyoshi, T., Moore, R., Ferguson, S., Negishi, M., and LeCluyse, E. (2003) J. Biol. Chem., 278, 14146–14152.
Yamada, H., Ishii, Y., Yamamoto, M., and Oguri, K. (2006) Curr. Drug Metab., 7, 397–409.
Wang, H., Faucette, S., Moore, R., Sueyoshi, T., Negishi, M., and LeCluyse, E. (2004) J. Biol. Chem., 279, 29295–29301.
Muangmoonchai, R., Smirlis, D., Wong, S. C., Edwards, M., Phillips, I. R., and Shephard, E. A. (2001) Biochem. J., 355, 71–78.
Min, G., Kemper, J. K., and Kemper, B. (2002) J. Biol. Chem., 277, 26356–26363.
Shiraki, T., Sakai, N., Kanaya, E., and Jingami, H. (2003) J. Biol. Chem., 278, 11344–11350.
Xie, Y. B., Nedumaran, B., and Choi, H. S. (2009) Nucleic Acids Res., 37, 4100–4115.
Kanno, Y., Suzuki, M., Nakahama, T., and Inouye, Y. (2005) Biochim. Biophys. Acta, 1745, 215–222.
Kakizaki, S., Yamamoto, M., and Ueda, A. (2003) Biochim. Biophys. Acta, 1619, 239–242.
Tzameli, I., Pissios, P., Schuetz, E. G., and Moore, D. D. (2000) Mol. Cell Biol., 20, 2951–2958.
Maglich, J. M., Parks, D. J., Moore, L. B., Collins, J. L., Goodwin, B., Billin, A. N., Stoltz, C. A., Kliewer, S. A., Lambert, M. H., Willson, T. M., and Moore, J. T. (2003) J. Biol. Chem., 278, 17277–17283.
Pustylnyak, V., Pivovarova, E., Slynko, N., Gulyaeva, L., and Lyakhovich, V. (2009) Life Sci., 85, 815–821.
Pustylnyak, V. O., Lebedev, A. N., Gulyaeva, L. F., Lyakhovich, V. V., and Slynko, N. M. (2007) Life Sci., 80, 324–328.
Mishin, V. M., Gutkina, N. I., Lyakhovich, V. V., Pospelova, L. N., and Chistyakov, V. V. (1990) Biokhimiya, 55, 29–36.
Jyrkkarinne, J., Windshugel, B., Makinen, J., Ylisirnio, M., Perakyla, M., Poso, A., Sippl, W., and Honkakoski, P. (2005) J. Biol. Chem., 280, 5960–5971.
Moore, L. B., Parks, D. J., Jones, S. A., Bledsoe, R. K., Consler, T. G., Stimmel, J. B., Goodwin, B., Liddle, C., Blanchard, S. G., Willson, T. M., Collins, J. L., and Kliewer, S. A. (2000) J. Biol. Chem., 275, 15122–15127.
Yoshinari, K., Kobayashi, K., Moore, R., Kawamoto, T., and Negishi, M. (2003) FEBS Lett., 548, 17–20.
Hosseinpour, F., Moore, R., Negishi, M., and Sueyoshi, T. (2006) Mol. Pharmacol., 69, 1095–1102.
Mutoh, S., Osabe, M., Inoue, K., Moore, R., Pedersen, L., Perera, L., Rebolloso, Y., Sueyoshi, T., and Negishi, M. (2009) J. Biol. Chem., 284, 34785–34792.
Saini, S. P., Sonoda, J., Xu, L., Toma, D., Uppal, H., Mu, Y., Ren, S., Moore, D. D., Evans, R. M., and Xie, W. (2004) Mol. Pharmacol., 65, 292–300.
Kullak-Ublick, G. A., and Becker, M. B. (2003) Drug Metab. Rev., 35, 305–317.
Olinga, P., Elferink, M. G., Draaisma, A. L., Merema, M. T., Castell, J. V., Perez, G., and Groothuis, G. M. (2008) Eur. J. Pharm. Sci., 33, 380–389.
Harris, R. Z., Jang, G. R., and Tsunoda, S. (2003) Clin. Pharmacokinet., 42, 1071–1088.
Gill, R. Q., and Sterling, R. K. (2001) J. Clin. Gastroenterol., 33, 191–198.
Schaffner, F. (1975) Vet. Pathol., 12, 145–156.
Rogers, L. K., Moorthy, B., and Smith, C. V. (1997) Chem. Res. Toxicol., 10, 470–476.
Zhang, J., Huang, W., Chua, S. S., Wei, P., and Moore, D. D. (2002) Science, 298, 422–424.
Tien, E. S., and Negishi, M. (2006) Xenobiotica, 36, 1152–1163.
Kakizaki, S., Yamazaki, Y., Takizawa, D., and Negishi, M. (2008) Curr. Drug Metab., 9, 614–621.
Sutija, M., and Joss, J. M. (2006) J. Comp. Physiol., 176, 87–92.
Tien, E. S., Matsui, K., Moore, R., and Negishi, M. (2007) J. Pharmacol. Exp. Ther., 320, 307–313.
Jeyakumar, M., Webb, P., Baxter, J. D., Scanlan, T. S., and Katzenellenbogen, J. A. (2008) Biochemistry, 47, 7465–7476.
Qatanani, M., Zhang, J., and Moore, D. D. (2005) Endocrinology, 146, 995–1002.
Min, G., Kim, H., Bae, Y., Petz, L., and Kemper, J. K. (2002) J. Biol. Chem., 277, 34626–34633.
Shan, L., Vincent, J., Brunzelle, J. S., Dussault, I., Lin, M., Ianculescu, I., Sherman, M. A., Forman, B. M., and Fernandez, E. J. (2004) Mol. Cell, 16, 907–917.
Rosenbrock, H., Hagemeyer, C. E., Singec, I., Knoth, R., and Volk, B. (1999) J. Neuroendocrinol., 11, 597–604.
Huang, W., Zhang, J., Washington, M., Liu, J., Parant, J. M., Lozano, G., and Moore, D. D. (2005) Mol. Endocrinol., 19, 1646–1653.
Yamamoto, Y., Moore, R., Goldsworthy, T. L., Negishi, M., and Maronpot, R. R. (2004) Cancer Res., 64, 7197–7200.
Ledda-Columbano, G. M., Pibiri, M., Cossu, C., Molotzu, F., Locker, J., and Columbano, A. (2004) Hepatology, 40, 981–988.
Columbano, A., Ledda-Columbano, G. M., Pibiri, M., Cossu, C., Menegazzi, M., Moore, D. D., Huang, W., Tian, J., and Locker, J. (2005) Hepatology, 42, 1118–1126.
Bilger, A., Bennett, L. M., Carabeo, R. A., Chiaverotti, T. A., Dvorak, C., Liss, K. M., Schadewald, S. A., Pitot, H. C., and Drinkwater, N. R. (2004) Genetics, 167, 859–866.
Hundal, R. S., Krssak, M., Dufour, S., Laurent, D., Lebon, V., Chandramouli, V., Inzucchi, S. E., Schumann, W. C., et al. (2000) Diabetes, 49, 2063–2069.
Manenti, G., Dragani, T. A., and Porta, G. D. (1987) Chem. Biol. Interact., 64, 83–92.
Argaud, D., Halimi, S., Catelloni, F., and Leverve, X. M. (1991) Biochem. J., 280, 663–669.
Nakae, J., Kitamura, T., Silver, D. L., and Accili, D. (2001) J. Clin. Invest., 108, 1359–1367.
Kodama, S., Koike, C., Negishi, M., and Yamamoto, Y. (2004) Mol. Cell. Biol., 24, 7931–7940.
Gao, J., He, J., Zhai, Y., Wada, T., and Xie, W. (2009) J. Biol. Chem., 284, 25984–25992.
Dong, B., Saha, P. K., Huang, W., Chen, W., Abu-Elheiga, L. A., Wakil, S. J., Stevens, R. D., Ilkayeva, O., Newgard, C. B., Chan, L., and Moore, D. D. (2009) Proc. Natl. Acad. Sci. USA, 106, 18831–18836.
Miao, J., Fang, S., Bae, Y., and Kemper, J. K. (2006) J. Biol. Chem., 281, 14537–14546.
Konno, Y., Negishi, M., and Kodama, S. (2008) Drug Metab. Pharmacokinet., 23, 8–13.
Gao, J., and Xie, W. (2010) Drug Metab. Dispos., 38, 2091–2095.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © E. M. Kachaylo, V. O. Pustylnyak, V. V. Lyakhovich, L. F. Gulyaeva, 2011, published in Biokhimiya, 2011, Vol. 76, No. 10, pp. 1335–1347.
Rights and permissions
About this article
Cite this article
Kachaylo, E.M., Pustylnyak, V.O., Lyakhovich, V.V. et al. Constitutive androstane receptor (CAR) is a xenosensor and target for therapy. Biochemistry Moscow 76, 1087–1097 (2011). https://doi.org/10.1134/S0006297911100026
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S0006297911100026